Navigation Links
Adjusting Market Research Structures and Activities to Maximize Payer Access & Insights
Date:7/16/2010

CHAPEL HILL, N.C., July 16 /PRNewswire/ -- As the managed markets sector has increased in importance, leading organizations have refocused their market research efforts on delivering actionable insights into the payer world. A market research function that's focused on managed markets should provide managers and executives with tactics to easily anticipate and act upon the needs and wants of third-party payers.

Recognizing the impact that market research groups can have on managed markets tactics and strategies, Best Practices, LLC has published a new data-rich written report to help biopharma executives navigate the new payer-oriented world.

"Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights" examines issues around the structure, staffing and activities of the market research function serving the managed markets group.

While the 67-page study confirms that pricing studies are considered an important prelaunch study, some executives felt payer landscape studies can actually provide more actionable insights.

One executive vice president noted landscape studies can help organizations better understand new generic penetration rates:

"Payer landscape is probably the most important study right now by far. You need to understand the landscape in big picture buckets - how many products are out there and how they're managed and the discount rates. Unless your product is novel, it's hard to get into the pharmacoeconomics of it -  so then it's just understanding the market you're entering and looking for indicators to decide if you're going to go high price, high price and high discount or low price and low discount." - Interviewed Executive Vice President

This study, which features 600+ metrics and 50 narratives such as the one above, is based on an analysis of survey results and interview content collected from 11 participating companies including Abbott Labs, Alcon, Amgen, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Novo Nordisk, Sepracor, Solvay, Ther-Rx and Xanodyne Pharmaceuticals.

To download a complimentary excerpt of this report, go to: http://www3.best-in-class.com/rr1012.htm.

Best Practices, LLC initiated this research to assist leaders of Market Research and Managed Markets in identifying tactics and success factors for understanding and acting upon the needs of third-party payers.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 46 out of the top 50 pharmaceutical companies. For more information visit: http://www3.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Heart Association Comment: Advisory Committee Recommends that U.S. Food and Drug Administration Keep Rosiglitazone (Avandia) on the Market, Continue Clinical Trial of Safety and Efficacy
2. ERT to Present at The BMO Capital Markets 10th Annual Focus on Healthcare Conference on August 5, 2010
3. MarketsandMarkets: Patient Monitoring Devices Markets in Brazil, Russia, India and China Worth $2,992 Million by 2015
4. Sanofi-Aventis and Novalar File Marketing Authorization Application for OraVerse® in Five Key European Countries
5. SeqWrights Partnership with EraGen Biosciences Contributes to FDA Market Clearance Success
6. International Drug & Explosives Detection Company Identa Corp Reports on New USA Marketing Representative
7. New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets
8. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
9. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
10. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
11. Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology:
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... With ... intervention to walk, the demand for a sustainable product to aid in the rehabilitation ... and aid in the recovery of individuals with hemiplegia due to stroke. , Ekso ...
(Date:5/27/2016)... ... May 27, 2016 , ... In response ... many who are unaware of the plight of aphasia. In collaboration with the ... “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively unknown, ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees in ... come courtesy of leaders in the nursing and health care industry. It also provides ... associations—namely Abilene Christian University. , As the nursing industry is coming out of ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... Despite last ... meeting, expect Janet Yellen and company to wait until March 2017 for an interest ... University’s J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) ...
(Date:5/26/2016)... ... 2016 , ... Cabot Corporation, Pfizer, and 3M are responsible ... documents and SEC filings. A jury has returned a verdict of $32.8 ... Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 million in ...
Breaking Medicine News(10 mins):